
A new drug shows promise against respiratory virus, study shows
CNN
A new antiviral medication against respiratory syncytial virus, or RSV, appears to be safe and lowered viral levels and symptoms significantly more than a placebo, according to the results of a study published Wednesday in The New England Journal of Medicine.
The study is unusual in that it is based on a two-part human challenge trial, where researchers purposefully infect people with a pathogen to test a new therapy. Challenge studies speed up research because scientists don't have to wait for their study participants to get sick out in the real world. They can also enroll fewer people, knowing that participants will inevitably catch a germ. But they're also risky and only considered ethical when the need for a new treatment or therapy is thought to outweigh the potential risks to study participants.
A winter virus that inundates pediatricians

A federal judge on Friday blocked President Donald Trump’s administration from enforcing most of his executive order on elections against the vote-by-mail states Washington and Oregon, in the latest blow to Trump’s efforts to require documentary proof of citizenship to vote and to require that all ballots be received by Election Day.

A Border Patrol agent shot two people in Portland, Oregon, during a traffic stop after authorities said they were associated with a Venezuelan gang, another incident in a string of confrontations with federal authorities that have left Americans frustrated with immigration enforcement during the Trump administration.











